Type 2 diabetes and heart risk in Saudi adults
Part of Heart & circulation clinical trials.
This study looks at how type 2 diabetes affects the risk of heart attacks and strokes in adults living in the western region of Saudi Arabia. If you have diabetes, researchers will review your records to learn more about preventing future heart problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have medical records available in the western region of Saudi Arabia
- You have been diagnosed with type 2 diabetes (this study is about people with diabetes)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study records health information to understand how type 2 diabetes and newly diagnosed heart disease affect people over time. It may help doctors learn what to watch for and how to plan care, though it is mainly an observational registry.
This study looks at people with type 2 diabetes who also have fatty liver. The goal is to learn more about this condition in a Saudi group and test approaches that could improve care.
This study looks at the health of people in Qatar who have heart or blood vessel disease, or are at very high risk for it. It may help find better ways to prevent heart attacks and strokes.
This study looks at the long-term risk of heart disease and death in people diagnosed with type 1 diabetes as adults. Researchers will compare their health to people without diabetes to understand how type 1 diabetes affects the heart over time.
This study looks at how newly diagnosed type 2 diabetes affects heart and blood vessel health. Researchers will follow patients over time to understand the relationship between diabetes and cardiovascular risk.
This study looks at medical records of people who were hospitalized for heart problems (heart attack or heart failure) and who also have diabetes or pre-diabetes. They use artificial intelligence to learn more about heart and metabolic health, which may help improve future care.
Hear when a new Cardiovascular Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.